[In-vitro and in-vivo studies on the selective immunoadsorption treatment of neurological diseases].
作者信息
Heininger K
出版信息
Schriftenr Neurol. 1993;33:1-91.
PMID:8327864
Abstract
摘要
相似文献
1
[In-vitro and in-vivo studies on the selective immunoadsorption treatment of neurological diseases].[神经疾病选择性免疫吸附治疗的体外及体内研究]
Schriftenr Neurol. 1993;33:1-91.
2
[Long-term treatment of refractory myasthenia gravis with immunoadsorption].[免疫吸附法长期治疗难治性重症肌无力]
Dtsch Med Wochenschr. 2008 Nov;133(46):2377-82. doi: 10.1055/s-0028-1100928. Epub 2008 Nov 4.
3
Elimination of IgG subclasses of anti-acetylcholine receptor antibodies in myasthenic plasma by immunoadsorption to protein A.通过蛋白A免疫吸附去除重症肌无力患者血浆中抗乙酰胆碱受体抗体的IgG亚类
Life Support Syst. 1985;3 Suppl 1:351-5.
4
Removal Characteristics of Immunoadsorption with the Tryptophan-Immobilized Column Using Conventional and Selective Plasma Separators in the Treatment of Myasthenia Gravis.使用常规和选择性血浆分离器的色氨酸固定化柱免疫吸附法治疗重症肌无力的去除特性
Ther Apher Dial. 2019 Jun;23(3):271-278. doi: 10.1111/1744-9987.12820. Epub 2019 May 29.
5
[Immunoadsorption--a new treatment of myasthenia gravis].[免疫吸附——重症肌无力的一种新疗法]
Med Klin (Munich). 1988 Feb 26;83(4):125-8.
6
Semi-selective immunoadsorption treatment in myasthenia gravis.重症肌无力的半选择性免疫吸附治疗
Biomater Artif Cells Immobilization Biotechnol. 1992;20(5):1145-51. doi: 10.3109/10731199209117341.
7
8
[Evaluation of plasma exchange in management of myasthenia gravis (author's transl)].血浆置换治疗重症肌无力的评估（作者译）
Rinsho Shinkeigaku. 1981 Jul;21(7):597-606.
9
Immunoadsorption therapy for myasthenia gravis.重症肌无力的免疫吸附疗法
J Neurol Neurosurg Psychiatry. 1994 May;57(5):578-81. doi: 10.1136/jnnp.57.5.578.
10
Plasma exchange with selective immunoadsorption of anti-acetylcholine receptor antibodies.血浆置换联合抗乙酰胆碱受体抗体的选择性免疫吸附
J Neuroimmunol. 1989 Apr;22(2):123-7. doi: 10.1016/0165-5728(89)90042-8.
Zotero 插件